跳至主要内容
临床试验/NCT04771728
NCT04771728招募中4 期

Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital

Peking University Shenzhen Hospital1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2020年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
140
试验地点
1
主要终点
Cure rate of BV

研究概览

简要总结

The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis

详细描述

Studies have shown that oral Probiotics(Umeta-mimi) can significantly promote the recovery of vaginal flora mainly because intestinal microbiota can migrate and affect vaginal microecology. This project aims to evaluate the efficacy of oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories(7 days) in the treatment of bacterial vaginosis (BV) and to explore the correlation between vaginal flora and fecal flora by detecting the metagenomics of vaginal secretions and intestinal feces at the time of baseline phase,14 days after treatment, the first month after treatment, 5-7 days after third menstruation after treatment and 5-7 days after sixth menstruation after treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged 18 to 55 years old, with history of sexual activity,
  • Amsel criterion for diagnosing BV
  • Sign informed consent

排除标准

  • History of systemic organic diseases or psychiatric diseases
  • Planning for or during pregnancy, lactation, menstruation
  • within 5 days of onset of the disease, any antibiotics has been used
  • Long-term use of contraceptives or immunosuppressant
  • Anaphylactic constitution or allergic to known ingredients of research drugs
  • No same fixed partner (RSP) before and after treatment

研究组 & 干预措施

Metronidazole vaginal

Active Comparator

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days )

干预措施: Metronidazole vaginal suppositories (Drug)

Metronidazole vagianl and Probiotics(Umeta-mimi)

Experimental

Metronidazole:Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days ) Probiotics:Oral Umeta-mimi( 5×109cfu per day,30 days)

干预措施: Metronidazole vaginal suppositories and Probiotics(Umeta-mimi) (Drug)

结局指标

主要结局

Cure rate of BV

时间窗: 14 days after treatment

Assessments with different Units of Measure:clinical symptoms such as itching or burning; "fishy" smell; homogeneous thin vaginal discharge;Nugent score; pH\>4.5; clue cell.

次要结局

  • Recurrence of BV(5-7 days after sixth menstruation after treatment)

研究者

发起方
Peking University Shenzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shangrong Fan

Professor of Dept of Obstetrics and Gynecology

Peking University Shenzhen Hospital

研究点 (1)

Loading locations...

相似试验